Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 19, 2016
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
Eric D Hamlett, Edward J Goetzl, Aurélie Ledreux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 17, 2014
Down syndrome and Alzheimer's disease: Common pathways, common goals
Dean Hartley, Thomas Blumenthal, Maria Carrillo, et al.
Drugs
|
September 28, 2025
Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial
Susan Abushakra, Aidan Power, David Watson, et al.
The Lancet. Neurology
|
May 2, 2021
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B Frisoni, et al.
The Lancet. Neurology
|
February 7, 2012
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling, Stephen Salloway, David J Brooks, et al.
Journal of Alzheimer'S Disease : JAD
|
October 18, 2024
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease
Howard H Feldman, Karen Messer, Yuqi Qiu, et al.
The New England Journal of Medicine
|
January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
Stephen Salloway, Reisa Sperling, Nick C Fox, et al.
Neurobiology of Aging
|
May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
Adam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
Neurology
|
July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies
David G Coughlin, Karen R MacLeod, John S Middleton, et al.
CNS Drugs
|
December 1, 2025
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials
Susan Abushakra, P Murali Doraiswamy, John A Hey, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 19, 2016
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
Eric D Hamlett, Edward J Goetzl, Aurélie Ledreux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 17, 2014
Down syndrome and Alzheimer's disease: Common pathways, common goals
Dean Hartley, Thomas Blumenthal, Maria Carrillo, et al.
Drugs
|
September 28, 2025
Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial
Susan Abushakra, Aidan Power, David Watson, et al.
The Lancet. Neurology
|
May 2, 2021
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B Frisoni, et al.
The Lancet. Neurology
|
February 7, 2012
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling, Stephen Salloway, David J Brooks, et al.
Journal of Alzheimer'S Disease : JAD
|
October 18, 2024
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease
Howard H Feldman, Karen Messer, Yuqi Qiu, et al.
The New England Journal of Medicine
|
January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
Stephen Salloway, Reisa Sperling, Nick C Fox, et al.
Neurobiology of Aging
|
May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
Adam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
Neurology
|
July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies
David G Coughlin, Karen R MacLeod, John S Middleton, et al.
CNS Drugs
|
December 1, 2025
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials
Susan Abushakra, P Murali Doraiswamy, John A Hey, et al.
Page
of 10